CLINDAMYCIN 1% / SODIUM SULFACETAMIDE MONOHYDRATE 5% / TRETINOIN 0.025%- clindamycin 1% / sodium sulfacetamide monohydrate 5% / tretinoin 0.025% gel
Sincerus Florida, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

CLINDAMYCIN 1% / SODIUM SULFACETAMIDE MONOHYDRATE 5% / TRETINOIN 0.025%

Directions for use

gsd

SIncerus Florida, LLC, Adverse reactions

sfd

Active, inactive

fdf

NDC 72934-1055-2. CLINDAMYCIN PHOSPHATE USP 1%/ SULFACETAMIDE SODIUM MONOHYDRATE USP 5% / TRETINOIN USP 0.025%. Gel 30gm.

CLINDAMYCIN 1% / SODIUM SULFACETAMIDE MONOHYDRATE 5% / TRETINOIN 0.025%
clindamycin 1% / sodium sulfacetamide monohydrate 5% / tretinoin 0.025% gel

Product Information
Product Type	HUMAN PRESCRIPTION DRUG	Item Code (Source)	NDC:72934-1055
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
CLINDAMYCIN PHOSPHATE (UNII: EH6D7113I8) (CLINDAMYCIN - UNII:3U02EL437C)	CLINDAMYCIN PHOSPHATE	1 g in 100 g
SULFACETAMIDE SODIUM (UNII: 4NRT660KJQ) (SULFACETAMIDE - UNII:4965G3J0F5)	SULFACETAMIDE SODIUM	5 g in 100 g
TRETINOIN (UNII: 5688UTC01R) (TRETINOIN - UNII:5688UTC01R)	TRETINOIN	0.025 g in 100 g

Product Characteristics
Color	yellow	Score
Shape		Size
Flavor		Imprint Code
Contains

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:72934-1055-2	30 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product	05/04/2019

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
unapproved drug other		05/04/2019

Labeler - Sincerus Florida, LLC (080105003)

Name	Address	ID/FEI	Business Operations
Establishment
Sincerus Florida, LLC		080105003	manufacture(72934-1055)